Notch Signaling in T-Cell Development and T-ALL
ISRN Hematology · 23.01.2011 · 2011 · 1-9
DOI: 10.5402/2011/921706 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Hematology, erschienen am 23.01.2011. Verfasst von Xiaoyu Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
The Notch signaling pathway is an evolutionarily conserved cell signaling system present in most multicellular organisms, as it controls cell fate specification by regulating cell proliferation, differentiation, apoptosis, and survival. Regulation of the Notch signaling pathway can be achieved at multiple levels. Notch proteins are involved in lineage fate decisions in a variety of tissues in various species. Notch is essential for T lineage cell differentiation including T versus B and αβ versus γδ lineage specification. In this paper, we discuss Notch signaling in normal T-cell maturation and differentiation as well as in T-cell acute lymphoblastic lymphoma/leukemia.
Autor:innen und Institutionen
- Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.
Förderung
- National Institutes of Health
Zitieren
APA
Li, X., & von Boehmer, H. (2011). Notch Signaling in T-Cell Development and T-ALL. ISRN Hematology, 2011, 1-9. https://doi.org/10.5402/2011/921706
Vancouver
Li X, von Boehmer H. Notch Signaling in T-Cell Development and T-ALL. ISRN Hematology. 2011;2011:1-9. doi:10.5402/2011/921706
BibTeX
@article{Li2011,
author = {Li, Xiaoyu and von Boehmer, Harald},
title = {Notch Signaling in T-Cell Development and T-ALL},
journal = {ISRN Hematology},
year = {2011},
volume = {2011},
pages = {1--9},
doi = {10.5402/2011/921706}
}
EUVIMED